6 08, 2020

CBD Can Improve Mental and Physical Health

By |2020-08-06T11:06:07-07:00August 6th, 2020|Brief Bulletins from the Field|0 Comments

With a vast range of medical and therapeutic benefits, CBD, or cannabidiol, is a derivative of the hemp plant. Researches have supported the claims that CBD may be a potential natural alternative to several traditional medicines. Consequently, CBD has become an ever-increasing industry. From pain-relieving balms to skin serums and [...]

29 07, 2020

A Comprehensive Update of Lofexidine for the Management of Opioid Withdrawal Symptoms

By |2020-07-29T09:04:39-07:00July 29th, 2020|Brief Bulletins from the Field|0 Comments

The current maintenance treatment for opiate withdrawal usually includes using a different, controlled, opiate, either methadone or buprenorphine. Alpha-2 receptor agonists, such as lofexidine, can be used to manage the acute symptoms during withdrawal. Lofexidine is effective and safe and is FDA approved for the management of withdrawal symptoms. It [...]

29 07, 2020

Naldemedine for the Use of Management of Opioid Induced Constipation

By |2020-07-29T08:59:49-07:00July 29th, 2020|Brief Bulletins from the Field|0 Comments

According to Urits and Viswanath, Opioid medications are fundamental in anesthesia and analgesia and are often used to treat acute and chronic pain. They achieve their desired effects by modulating pain perception in the central nervous system; however, they also act on opioid receptors in the periphery, causing many undesirable [...]

4 06, 2020

Antiepileptic Drugs and Bone Health: Current Concepts

By |2020-06-04T10:53:56-07:00June 4th, 2020|Brief Bulletins from the Field, We Know Psychiatry|0 Comments

Chronic use of antiepileptic drugs (AEDs) can induce the development of adverse effects on bone metabolism. In epileptic patients treated with AED, the monitor- ing of biochemical markers of bone turnover, such as the measurement of serum 25 (OH) vitamin D, bone mineral density, before the beginning of the treatment [...]

4 06, 2020

Demographic Variation in the Use of Prazosin for Treatment of Sleep Disturbance in Combat Veterans with PTSD

By |2020-06-04T10:47:07-07:00June 4th, 2020|Brief Bulletins from the Field, We Know Psychiatry|0 Comments

ABSTRACT ~ Objective: Off-label use of prazosin for posttraumatic stress disorder-related sleep disturbances (PTSD-SD) is widespread in Veterans Health Administration (VA) settings, but clinical trials have had mixed results. Trial criteria may exclude significant sub-groups, and therefore a 2018 study may not provide the final evidence of prazo- sin efficacy [...]

4 06, 2020